Obesity Trial, Recruiting NCT06622382 Sponsor: Chinese University of Hong Kong Condition: Obesity
Back to Obesity

Obesity Trial, Recruiting

NCT06622382
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People with a Body Mass Index (BMI) between 30 and 40 (or between 27.5 and 40 for people of Chinese or South Asian background), OR people with a BMI over 40 who are considered too high-risk for surgery or who do not wish to have surgery
  • People who have already tried standard weight loss approaches — such as diet, exercise, behaviour changes, and weight loss medications — without sufficient success, either separately or in combination

Who may not be able to join:

  • People who have previously had surgery on the upper digestive system, such as weight loss surgery, anti-reflux surgery, stomach removal, or oesophageal surgery
  • People diagnosed with gastroparesis (a condition where the stomach empties too slowly)
  • People who currently smoke
  • People who have used opioid pain medications at any point in the 12 months before enrolling
  • People who have previously had certain surgical procedures on the valve between the stomach and small intestine (pyloromyotomy or pyloroplasty)
  • People with a blockage anywhere in the digestive tract
  • People currently taking medications that may affect weight loss or how quickly the stomach empties
  • People with serious blood clotting problems
  • People with varicose veins in the oesophagus or stomach, or related stomach lining changes caused by liver pressure
  • People with an uncontrolled hormonal or glandular condition that is causing their weight gain, such as an underactive thyroid, Cushing's syndrome, or an eating disorder
  • People with inflammatory conditions of the digestive tract, such as severe oesophagitis, active stomach or duodenal ulcers, or conditions like Crohn's disease
  • People with a current or recent cancer diagnosis
  • People who are pregnant or breastfeeding
  • People who are not considered medically safe to undergo general anaesthesia
  • People rated as ASA Grade IV or V, meaning those with severe or life-threatening medical conditions (confirm with trial site)
  • People with a mental health or psychiatric condition, or a current problem with drug or alcohol use
  • People whom the examining doctor considers unsuitable for safe participation for any other reason
  • People who do not wish to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Stephen Ng, FRCSEd(Gen), Prince of Wales Hospital, the Chinese University of Hong Kong

Phone: +85235052956

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
12 September 2024
Est. completion
30 September 2026

Where this trial is recruiting

Hong Kong

Primary endpoints

Body weight; Adverse events

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov